13G Filing: Great Point Partners and Catalyst Pharmaceuticals Inc. (CPRX)

Page 3 of 10

Page 3 of 10 – SEC Filing

CUSIP
No.   14888U101
13G Page
3 of 9 Pages
1.

NAMES OF REPORTING PERSONS

Dr. Jeffrey R. Jay, M.D.

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
3. SEC USE ONLY
   
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING PERSON

WITH

5. SOLE VOTING POWER
0
6. SHARED VOTING POWER
5,262,346
7. SOLE DISPOSITIVE POWER
0
8. SHARED DISPOSITIVE POWER
5,262,346
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,262,346
   
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  o
     
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.14%1
   
12. TYPE OF REPORTING PERSON (See Instructions)
IN

Follow Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX)

Page 3 of 10